-
Chemspace and LabNetwork collaborate to extend access to chemical databases
Feb 13, 2019, 07:08 AM by Michael Croft, RIGA, LATVIA AND SHANGHAI, CHINA - Feb 13, 2019 - Chemspace and LabNetwork, a WuXi AppTec company, both online marketplaces for chemical compounds used in drug discovery, today announced they have entered into a collaboration agreementFull story -
Victa Biotherapeutics Appoints Donald W. Kufe to Board of Directors
Feb 12, 2019, 09:11 AM by Michael CroftCAMBRIDGE, MA, UNITED STATES - Feb 12, 2019 - HiFiBiO Therapeutics, a world leader in the discovery and development of therapeutic antibodies enabled by unique single-cell profiling and full immune repertoire screening, today announced Donald WFull story -
From Patient-Centric Technologies to Clinical Trial Supply Chain Management, CRF Bracket Moves Clinical Trials Forward at the 10th Annual SCOPE Summit
Feb 12, 2019, 09:06 AM by Michael CroftPLYMOUTH MEETING, PA - Feb 12, 2019 - Running a seamless clinical trial means improving not only data quality but also operational logistics and most importantly the patient experienceFull story -
FreeLIMS Launches New Version of its LIMS
Feb 12, 2019, 07:50 AM by Michael CroftSAN FRANCISCO, CA, US - Feb 12, 2019 - FreeLIMS announces the release of a new version of its free Laboratory Information Management System (LIMS), FreeLIMSFull story -
Recipharm appoints new Director of Business Management
Feb 12, 2019, 06:13 AM by Michael CroftSTOCKHOLM, SWEDEN - Feb 12, 2019 - Recipharm, the contract development and manufacturing organisation (CDMO), has appointed a new director of business management for the USA and Canada to accelerate growth in the regionFull story -
The Bioinformatics Infrastructure Congress launches in Boston, May 2019
Feb 11, 2019, 10:47 AM by Michael CroftBOSTON, MA - May 7, 2019 - Kisaco Research is delighted to announce the launch of the Bioinformatics Infrastructure Congress running in Boston on May 8-9th, 2019Full story -
Trump To Sign Executive Order Promoting Artificial Intelligence
Feb 11, 2019, 10:09 AM by Michael CroftThe New York Times | President Trump is expected to sign an executive order meant to spur the development and regulation of AI. But the order does not set aside additional funds for AI development, and officials provided few details on how it will track the progress of its new policies.Full story -
Clinical Genomics Insights In Hematological Malignancies Require Streamlined Bioinformatics Solutions
Feb 8, 2019, 11:25 AM by Michael CroftFull storyBio-IT World Contributed Commentary | Next-generation sequencing has transformed the field of oncology. Early successes in identifying and targeting oncogenic drivers of solid tumors have set the foundation for genomics-guided precision medicine; but, for hematological malignancies, the path to precision medicine is a lot more complex.
-
The Pistoia Alliance Launches Next Phase of Blockchain Project to Develop Life Science R&D Use Cases
Feb 8, 2019, 11:01 AM by Michael CroftBOSTON, MA - Feb 8, 2019 - The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life sciences R&D, is today launching the next phase of its blockchain projectFull story -
Certara Advances Global Initiative to Take Model-informed Precision Dosing (MIPD) Into the Clinic
Feb 7, 2019, 13:16 PM by Michael CroftPRINCETON, NJ - Feb 7, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced its latest advances in bringing model-informed precision dosing (MIPD) to the point of careFull story -
Clinithink secures growth-equity investment to fuel growth
Feb 7, 2019, 11:07 AM by Michael CroftLONDON, UNITED KINGDOM - Feb 7, 2019 - Leading healthcare technology investors partner with Clinithink to unlock the potential of unstructured data to inform treatment decisions, identify candidates for clinical trials, and ensure appropriate reimbursement Clinithink, which offers healthcare and life sciences organizations powerful clinical data insights through its patented CLiX natural language processing (NLP) platform, has secured a growth-equity investment from TT Capital Partners (TTCP) and the MSD Global Health Innovation Fund (GHI) to expand its global footprint and continue to broaden its service offeringFull story -
New Time Saving and Fully Automated Digital Microscope Delivers High Quality Cell Imaging and Data to Scientists
Feb 6, 2019, 12:19 PM by Michael CroftCARLSBAD, CA, UNITED STATES - Feb 6, 2019 - For biological researchers requiring high-quality images and data from their cells and samples without over-investing time and resources to get them, the fully automated Invitrogen EVOS M7000 microscope features a high-end camera and more powerful computer to deliver better images in less timeFull story -
CRF Bracket Becomes a Leading Employer in Romania Two Years after Establishing Office as Demand for Trustworthy Global Support of eClinical Solutions Continues to Grow
Feb 6, 2019, 09:14 AM by Michael CroftPLYMOUTH MEETING, PA - Feb 6, 2019 - CRF Bracket is celebrating unprecedented success in Romania after opening an eClinical technology facility in the country just two years agoFull story -
Sharp enhances IRT solution with latest investment
Feb 6, 2019, 06:56 AM by Michael CroftBETHLEHEM, PA - Feb 6, 2019 - The companys clinical services division supports pharma and biotech clients from phase I trials all the way through to commercializationFull story -
Mark Johnson joins The RSA Group as Partner
Feb 6, 2019, 05:12 AM by Michael CroftLONDON, UK - Feb 6, 2019 - The RSA Group, a leading Life Sciences executive search firm, announced today that Mark Johnson has joined the company as a PartnerFull story -
Oxford Nanopore Launches cDNA Kits
Feb 5, 2019, 11:45 AM by Michael CroftBio-IT World News Brief Oxford Nanopore has launched new ‘109’ cDNA Kits for its real-time, scalable sequencing technology. The new kits provide high throughput while generating complete sequences of full-length cDNA strands, with a low input option of just 1 ng PolyA+ RNA.Full story -
IQVIA Launches IQVIA Biotech, Dedicated to Emerging Biotech and Biopharma Industry
Feb 5, 2019, 10:17 AM by Michael CroftDANBURY, CT - Feb 4, 2019 - (BUSINESS WIRE) - IQVIA (NYSE:IQV) today announced the launch of IQVIA Biotech and its new approach to delivering tailored clinical and commercial solutions for small biotech and biopharma companiesFull story -
CRISPR's Gene Editing Toolbox Is Expanding
Feb 5, 2019, 09:52 AM by Michael CroftLos Angeles Times | The scientists who developed the revolutionary gene-editing system known as CRISPR are improving it with new tools that make it work better.Full story -
Genedata Announces Bruker as a New Ready-to-Run Partner
Feb 5, 2019, 09:17 AM by Michael CroftWASHINGTON, DC, UNITED STATES - Feb 5, 2019 - Genedata, a leading provider of advanced software solutions for biopharmaceutical R&D, today announced Bruker, a preeminent provider of high-performance scientific instruments and high-value analytical and diagnostic solutions, as a new Genedata Ready-to-Run partnerFull story -
GA4GH Adds Seven Genomic Data Initiatives As New Driver Projects
Feb 4, 2019, 16:35 PM by Michael CroftFull storyBio-IT World News Brief | The Global Alliance for Genomics and Health (GA4GH) has named seven of the world’s leading genomic data initiatives as new Driver Projects for 2019.